| Home : March 2020 : March 19, 2020 News : Cellphire Begins Phase 2 Trial of Thrombosomes® in Bleeding Thrombocytopenic Patients |
Cellphire Begins Phase 2 Trial of Thrombosomes® in Bleeding Thrombocytopenic Patients |
March 19, 2020
ROCKVILLE, Md., March 18, 2020 /PRNewswire/ -- Cellphire, Inc., the global leader in long-term stabilization and storage of platelets, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to start a Phase 2 clinical trial of Thrombosomes in...
https://www.prnewswire.com:443/news-releases/cellphire-begins-phase-2-trial-of-thrombosomes-in-bleeding-thrombocytopenic-patients-301026462.html
|
|
|
 Other Stories |
|
|
|
|
|
|
|
|
|
|
|
